deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT02489500

Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib (VelRand)

Phase III Trial of High-dose Melphalan and Stem Cell Transplantation Versus High-dose Melphalan and Bortezomib and Stem Cell Transplantation in Patients With AL Amyloidosis

Sponsor: Boston Medical Center

Conditions AL Amyloidosis
Interventions Bortezomib Melphalan Neupogen Stem Cell Collection Stem cell infusion
Updated 11 times since 2017 Last updated: Aug 10, 2018 Started: Jun 30, 2015 Primary completion: Apr 28, 2017 Completion: Apr 28, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Enrollment held for toxicity evaluation; then closed due to competing trial

Other terminated trials from Boston Medical Center

See all terminations from Boston Medical Center

A PHASE3 clinical study on AL Amyloidosis, this trial is terminated or withdrawn. The trial is conducted by Boston Medical Center and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotSuspended~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotSuspended~Aug 2017 – ~Dec 2017 · 4 months · monthly snapshotTerminated~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotTerminated~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotTerminated~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshotTerminated~Oct 2018 – ~Jan 2021 · 27 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE3

  5. Oct 2018 — Jan 2021 [monthly]

    Terminated PHASE3

▶ Show 6 earlier versions

  1. Sep 2018 — Oct 2018 [monthly]

    Terminated PHASE3

  2. Jun 2018 — Sep 2018 [monthly]

    Terminated PHASE3

  3. Dec 2017 — Jun 2018 [monthly]

    Terminated PHASE3

  4. Aug 2017 — Dec 2017 [monthly]

    Terminated PHASE3

    Status: Suspended → Terminated

  5. Feb 2017 — Aug 2017 [monthly]

    Suspended PHASE3

  6. Jan 2017 — Feb 2017 [monthly]

    Suspended PHASE3

    First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston Medical Center
Data source: Boston Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations